• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Viz.ai

Viz.ai, NICO collaborate to improve intracerebral hemorrhage treatment

April 17, 2024 By Danielle Kirsh

Viz.ai today announced a collaboration with NICO Corporation to help improve the lives of patients with intracerebral hemorrhages. Intracerebral hemorrhage (ICH) is caused by bleeding in the brain tissue and is a life-threatening type of stroke. It accounts for up to 15% of all strokes and has high morbidity and mortality rates. Viz-ai’s technology can […]

Filed Under: Artificial Intelligence (AI), Hospital Care Tagged With: NICO, Viz.ai

FDA clears Viz.ai algorithm for quantifying intracerebral hemmorhage

February 9, 2024 By Sean Whooley

Viz.ai announced that it received FDA 510(k) clearance for its Viz ICH Plus algorithm for providing volume measurements of brain bleeds. Viz ICH Plus automates the process of identifying, labeling and quantifying the volume of segmentable brain structures on non-contrast computed tomography (NCCT) images. The company designed it to analyze intracranial hyperdensities, lateral ventricles and […]

Filed Under: News Well Tagged With: Viz.ai

FDA grants de novo nod to hypertrophic cardiomyopathy AI algorithm from Viz.ai

August 15, 2023 By Sean Whooley

Viz.ai announced today that the FDA granted de novo approval to its Viz HCM module for detecting hypertrophic cardiomyopathy. San Francisco-based Viz.ai says this creates a new regulatory category for cardiovascular machine learning-based notification software. The company supports its algorithm’s deployment through a multi-year agreement with Bristol Myers Squibb. They struck that partnership deal in […]

Filed Under: Big Data, Cardiovascular, Diagnostics, Digital Health, Electronic Medical Records (EMR), Featured, Food & Drug Administration (FDA), Health Technology, Hospital Care, News Well, Patient Monitoring, Regulatory/Compliance, Software / IT Tagged With: Viz.ai

FDA clears Viz.ai algorithm that detects abdominal aortic aneurysm

March 21, 2023 By Sean Whooley

Viz.ai announced today that it received FDA 510(k) clearance for its algorithm that detects suspected abdominal aortic aneurysm (AAA). The company said in a news release that this marks the first FDA-cleared, AI-powered solution for detecting and triaging suspected AAA. Viz.ai’s AI algorithm automatically searches for the presence of an abdominal aortic aneurysm from any […]

Filed Under: 510(k), Business/Financial News, Cardiovascular, Diagnostics, Digital Health, Food & Drug Administration (FDA), Health Technology, Imaging, Patient Monitoring, Regulatory/Compliance, Software / IT, Vascular Tagged With: FDA, Viz.ai

Viz.ai partners with Bristol Myers Squibb on early hypertrophic cardiomyopathy detection

March 3, 2023 By Sean Whooley

Viz.ai announced today that it entered into a multi-year agreement with Bristol Myers Squibb (NYSE:BMY) for detecting hypertrophic cardiomyopathy. The partnership seeks to deploy an AI algorithm and the Viz HCM provider workflow software. This can help identify and triage patients who may require further evaluation for the detection of hypertrophic cardiomyopathy. San Francisco-based Viz.ai […]

Filed Under: Business/Financial News, Cardiovascular, Diagnostics, Digital Health, Health Technology, Software / IT Tagged With: Bristol-Myers Squibb Co., Viz.ai

Viz.ai launches AI-powered vascular suite

January 13, 2023 By Sean Whooley

Viz.ai announced that it launched its Viz Vascular Suite for detecting and triaging care for a range of suspected vascular conditions. Those conditions include pulmonary embolism, right heart strain, aortic dissection and abdominal aortic aneurysm (AAA). San Francisco-based Viz.ai submitted a 510(k) application to the FDA for the AI-powered software, according to a news release. […]

Filed Under: Business/Financial News, Digital Health, Health Technology, Hospital Care, Software / IT, Vascular Tagged With: Viz.ai

Viz.ai launches AI-powered radiology suite

November 28, 2022 By Sean Whooley

Viz.ai announced today that it launched an AI-powered radiology suite for alerting radiologists and connecting care teams in real-time. San Francisco-based Viz.ai designed the suite to alert radiologists in their workflow of suspected diseases. It also prioritizes worklists and connects care teams while integrating into picture archiving and communications systems (PACS). This helps to securely […]

Filed Under: Business/Financial News, Digital Health, Health Technology, Hospital Care, Imaging, Oncology, Radiosurgery/Radiation therapy, Software / IT Tagged With: Viz.ai

Viz.ai names Jieun Choe as chief marketing officer

October 25, 2022 By Danielle Kirsh

Viz.ai this week announced it appointed Jieun Choe as chief marketing officer. Choe will report directly to CEO Chris Mansi and will oversee the global marketing strategy, brand and communications, product marketing and demand generation for the San Francisco-based company. “Jieun’s deep experience and proven track record in driving growth with expert execution will be […]

Filed Under: Business/Financial News, Diagnostics Tagged With: Personnel Moves, Viz.ai

FDA clears new Viz.ai algorithm for measuring ventricles in identifying pulmonary embolism

September 1, 2022 By Sean Whooley

Viz.ai announced today that it received FDA 510(k) clearance for its automated RV/LV ratio algorithm as part of the Viz PE solution. San Francisco-based Viz.ai designed its algorithm to quickly and accurately measure the diameter of the ventricles of the heart. The measurements provide the ratio of the maximum right ventricle (RV) diameter versus left […]

Filed Under: 510(k), Business/Financial News, Cardiovascular, Digital Health, Food & Drug Administration (FDA), Health Technology, Regulatory/Compliance, Software / IT, Vascular Tagged With: FDA, Viz.ai

FDA clears Viz.ai’s algorithm that detects subdural hemorrhage

July 27, 2022 By Sean Whooley

Viz.ai announced today that it received FDA 510(k) clearance for its Viz Subdural (SDH) artificial intelligence (AI) algorithm. San Francisco-based Viz.ai designed its Viz SDH algorithm to use AI to automatically detect subdural hemorrhage, enabling physicians to triage patients effectively and deliver optimal care. The company said in a news release that its Viz SDH […]

Filed Under: 510(k), Blood Management, Business/Financial News, Digital Health, Food & Drug Administration (FDA), Health Technology, Hospital Care, Regulatory/Compliance, Software / IT Tagged With: Viz.ai

Viz.ai, Hyperfine partner on new MRI, workflow paradigm

July 26, 2022 By Sean Whooley

Viz.ai announced today that it partnered with Hyperfine (Nasdaq:HYPR) to bring magnetic resonance imaging (MRI) to the patient’s bedside. San Francisco-based Viz.ai develops the Viz LVO, its flagship product designed to leverage advanced deep learning to communicate time-sensitive information about stroke patients straight to a specialist who can intervene and treat the patient. Hyperfine develops […]

Filed Under: Business/Financial News, Health Technology, Imaging, Neurological, Software / IT Tagged With: Hyperfine, Viz.ai

  • Page 1
  • Page 2
  • Page 3
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy